TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Motor Skill Retention
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: AUC(Inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C(Max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PedMIDAS score (measure of migraine severity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Spatial Patterns of Brain Network Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Shock index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in CSDD (Cornell scale for depression in dementia)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of incident radiological hemorrhagic transformation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Level of antibiotics in umbilical vein cord blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Average tonal gain (dB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in auditory hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minor Ischemia During Hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major Ischemia During Hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major Bleeding During Hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Whole improvement level
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CIV response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Clinical Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Mycological Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence or absence of cytological atypia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Condom use self efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progress free survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Maximum Tolerance Dose (MTD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MCCormack scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: levels of Daptomycin in drainage fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: levels of Daptomycin in blood samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical success at follow-up
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: clinical criteria sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of analgesic requests
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: diagnostic accuracy of pleural biopsy specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Patient Global Assessment (PGA)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of positive trypanosoma cruzi serologies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in plasma homocysteine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in hepatic GSH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in hepatic expression of TNF, MAT1A, MAT2A, MS, CBS and BHMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: voiding function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Differentiation between normal and malignant tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of Maternal Sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sepsis related maternal mortality
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of Multidrug Resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Surgical Incision Complications
Endpoint domain: Adverse events/effects
Primary endpoint: POCUS Score - Lungs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: POCUS Score - Heart
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Regional Wall Motion Abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median Best Response of Cutaneous Neurofibromas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Patient-Reported Outcomes-Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Endpoint domain: Adverse events/effects
Primary endpoint: 5-level EQ-5D version (EQ5D5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: COVID-19 Peritraumatic Distress Index (CPDI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: number of responses from patients to yes/no questions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of responses from caregivers to yes/no questions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: number of responses from physicians to yes/no questions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subcutaneous Anti-TNF Treatment Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change From Baseline in Urine 23S-Pentol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to exercise compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to relapse after cessation of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct answers to COVID-19 knowledge questions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Adherence to COVID-19 preventive measures
Endpoint domain: Life impact
Endpoint subdomain: Behavioral outcomes
Primary endpoint: Change in lower back pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: AUC DCI-IPG (%/Min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fasting Serum Insulin (uIU/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Two-year bladder-intact disease-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: LoSCAT target lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline in 6-min-walk distance (6-MWD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: scale of rating of ataxia (SARA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SCA Functional Index Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ5D3L - quality of life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Success rates of fiberscope-guided NG tube insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Global Impression of Change Rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intussusception Within 42 Days Following Any Dose of RotaTeq™/Placebo
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Rotavirus Disease Caused by Serotypes G1, G2, G3 and G4 That Occurs 14 Days Following the 3rd Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of the iball intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection of precancerous cervical lesions or cervical cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in mean 24-hr ambulatory systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in tumour SUV from baseline to Day 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety attributable to 111In-Pertuzumab injections
Endpoint domain: Adverse events/effects
Primary endpoint: Leg Strength and Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent of Resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of lymph nodes containing 99mTc-Dextran
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Prevalence of hypogonadism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Late complications of radiation therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Acute and subacute toxicities of radiation therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Prothrombin Fragment 1+2 Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Complete clinical response of cryoglobulinaemia vasculitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity of Inactivated Poliomyelitis Vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Frequency of flare-ups
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life (QoL) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of patients with CD8 immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incremental area under curve (iAUC) blood glucose response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in fruits and vegetables and dairy products
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: safety/tolerability of combination treatment
Endpoint domain: Adverse events/effects
Primary endpoint: safety/tolerability of SB-485232
Endpoint domain: Adverse events/effects
Primary endpoint: Change in mean number of micturitions per 24h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Days Until Restart of ART
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax - Maximum Plasma Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of All Clinical Symptoms of cUTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Annualized Relapse Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants and Type of Reported Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Subjects Who Experience a New Cold Sore Outbreak That Proceeds to the Lesion Stage
Endpoint domain: Adverse events/effects
Primary endpoint: Angina class as assessed by the CCS Class
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of life using the Seattle Angina Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Area Under the Curve (AUC) From Time Zero to the Time of the Last Quantifiable Concentration (AUC0-t) of Zanubrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Zanubrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apparent Terminal Elimination Half-life (t1/2) of Zanubrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean baseline regional cerebral oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Uncorrected Near Visual Acuity 20/32 or Better
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of arterial stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Without-fail Care Rate
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Progressive Supranuclear Palsy Rating Scale (PSPRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corticobasal Degeneration Functional Scale (CBDFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UDS Neuropsychological Testing Battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dysphoric-like depressive characteristics
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in hemoglobin A1c from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PANSS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CAPS-SX total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Top Problems Assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concordance of DNA mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Gastrointestinal tolerance for bowel movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastrointestinal tolerance for vomit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage Change in mPASI Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: 6 minutes walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: endsystolic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: HBV DNA titer < 300 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detected pelvic and paraaortic sentinel lymph node numbers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Adherence to Mediterranean diet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in average daily steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of abstinence of tobacco
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Intention to undergo CRC screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Conner's Parent Rating Scale (CPRS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Formation of new granulation tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in MADRS total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Participants With ACR20 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change From Baseline in mTSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Annual Completion of the FIT Kit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number Participants With Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Concentration-time Curve From Time 0 to Infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Adrenal Insufficiency
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Experienced at Least One Adrenal Crisis
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Pre-Chronocort Baseline to Month 30 in Vital Signs - Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in BOLD Signal in Anterior Cingulate Cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Cognitive Control Network Functional Connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: S-Lanss (assessment of neuropathic symptoms and signs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: VAS (Visual Analogue Scale)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: DASH (Disabilities of the arm, shoulder, hand)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: LEFS (Lower extremity functional scale)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cmax of Norethindrone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of Norethindrone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Ethinyl Estradiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of women who stop prolonged uterine bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Point prevalence abstinence from smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychological General Well-Being (PGWB) Index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean Percent Days of Total Shedding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of Adverse Effects (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum concentration (Cmax) of BMS-986322 in Part C
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematology, clinical chemistry, urinalysis, vital signs, ECG intervals, ECG rhythm telemetry, pulmonary function tests, respiratory rate and lung auscultation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain in Recovery Room
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sexual Self-Confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Serum levels of β-Cx
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum levels of PS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for re-interventions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: need for re-hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: complete or partial liver drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change from baseline in OCT retinal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression Free Survival Rate (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Airway Blood Flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: TNF alpha levels in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cellular response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Intraoperative VEP changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean haemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of pain in the stump or phantom limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of phantom limb sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti-tumor response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: change in conduit artery function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: IV Catheter Survival
Endpoint domain: Mortality/survival
Primary endpoint: Change in Levels of Aggression Score From Baseline to Month 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Levels of Aggression Score From Baseline to Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Post Test Behavioral Infractions
Endpoint domain: Adverse events/effects
Primary endpoint: Median Number of Days in Administrative Segregation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Duration of Severe Neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Cardiac Death/TV-MI/ID-TLR
Endpoint domain: Mortality/survival
Primary endpoint: Patient Health Questionnaire (PHQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Peak Ekspiratuar Flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Forced Expiratory Volume First Second
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes